Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Testing different facemasks for noninvasive ventilation in respiratory failure

Official title: Physiological Effects of Novel Noninvasive Ventilation Facemasks Favoring Carbon Dioxide Washout in Patients With Hypercapnic Respiratory Failure

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06483984 · Data updated 2026-11-12

This study tests which of three different facemasks works best for helping people with severe breathing problems get rid of carbon dioxide.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Locations2 sites (Roma and 1 other locations)
StatusRecruiting
StartedNovember 15, 2024
Main results expectedOctober 1, 2026
Study endsOctober 1, 2026
Registry record updatedSeptember 30, 2025
Trial IDNCT06483984 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with acute respiratory failure characterized by elevated carbon dioxide levels and low arterial pH.

Probably not a fit

Patients who require immediate intubation or have severe hemodynamic instability will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates the physiological effects of three types of facemasks used for noninvasive ventilation in patients experiencing acute hypercapnic respiratory failure. Participants will be randomly assigned to use either the Nivairo, Visairo, or Optiniv facemask to determine which is most effective at facilitating carbon dioxide washout. The study aims to improve treatment options for patients with respiratory insufficiency by comparing these interventions. The trial will include measurements of arterial blood gases and other relevant physiological parameters.

Why it matters

Potential benefit: If successful, this study could lead to improved noninvasive ventilation strategies for patients with respiratory insufficiency.

How similar studies have gone: While there have been studies on noninvasive ventilation, the specific comparison of these three facemasks is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Acute respiratory failure with

* PaCO2 ≥ 45 mmHg;
* Arterial pH \< 7.35;
* Signed written informed consent

Exclusion Criteria:

* Respiratory rate \< 12 bpm;
* Immediate need for intubation;
* Haemodynamic instability (Systolic blood pressure \<90 mmHg or mean arterial pressure \<65 mmHg) and/or lactic acidosis (lactate \>5 mmol/L) and/or clinically diagnosed shock;
* Metabolic Acidosis;
* Recent head surgery or anatomy that prevent the application of facemasks;
* Any contraindications to oesophageal balloon insertion and/or electrical impedance tomography (EIT) belt placement.
* Any contraindications to facemask noninvasive ventilation.

Where it's running

  • General intensive care unit, Fondazione Policlinico A. Gemelli IRCCS
    Roma, Italy
    Recruiting
  • Fondazione Policlinico Universitaro A. Gemelli IRCCS
    Rome, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.